Appointment of Executive Chairman at ADAM
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Professor Steve Myers OBE, Head of Medical Applications at CERN, has been appointed as Executive Chairman of Advanced Oncotherapy's fully owned subsidiary ADAM S.A ("ADAM").
ADAM was founded in 2007 as a spin-off from CERN, the European Organisation for Nuclear Research, and was acquired by Advanced Oncotherapy in 2013. The...
AVO announces signed Share Purchase Agreement with ADAM, a CERN spin-off company founded by
Dr Alberto Colussi.
Read more here
19 April 2012
Accelerators and Medicine by Donatella Ungaro
8-15 May 2011
PTCOG 50, UPenn, Philadelphia, Pennsylvania, USA